Interesting OncBioMune Pharmaceuticals acquired Avant Diagnostics, Inc for 4.4 billion shares of OncBioMune’s common stock. Which AMBS owns 31% of Avant diagnostics, could receive 1.36B shares of $OBMP.
IS THIS TRUE?
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
